Forbeck Scholars are selected through a highly competitive process. The Scientific Advisory Board says that each year it is difficult to make their selection due to the number of outstanding candidates. The Scholars attend the Annual Forum in their first year which gives them the opportunity to work with the leaders in their field. For the following 4 years they attend the Scholar Retreat where they collaborate with peers from various areas of cancer research. This meeting has been highly successful at bringing together collaborations between researchers from various areas of cancer research.
By Sponsoring a Scholar, you are supporting a specific candidate, of your choice, to attend these meetings and get to follow their progress over their years. Many of our scholars have gone on to become highly acclaimed researchers, directors of institutions, and are the future of cancer research.
A pledge of $1,000 each year (totaling $3,000)
The Forbeck Foundation would welcome title sponsors for any upcoming meetings. This is a great way to memorialize or honor those who have battled cancer or to get publicity for your company. Whatever your goal we can help you make an impact!
Title sponsorship for a meeting is $30,000.
The best way for the Forbeck Foundation to continue funding research is through events where we can have fun while spreading the word about what we do. Please contact us if you would consider hosting an event. The foundation staff can help with any logistics for an event. There are many ways to raise funds while also having some fun and we would love to work with you on an event!
Donate up to 30% of your purchase price to The William Guy Forbeck Research Foundation when you shop at 3,000+ popular online retailers using Giving Assistant! It’s easy. Giving Assistant pays you cash back, and you choose how much of it you’d like to donate to us. Try it now and find great deals like exclusive Joann coupons, as well as savings at great places like ULTA and Macy's!
“The Scientific Advisory Board chooses Forum topics to reflect the most pressing contemporary issues in cancer research at any time.”
Gerard Evan, PhD, University of Cambridge